Showing results (121-130 of 673) with videos related to
Sort By:
Pageof 68
Orvosi Hetilap|January 10, 2002
[Clinical, microbiological and therapeutic aspects of oral candidiasis (candidosis)]P Hermann, Z Berek, K Kamotsay, et al.Biological Psychiatry|December 15, 1991
Mood state in unilateral temporal lobe epilepsyB P Hermann, M Seidenberg, A Haltiner, et al.Der Radiologe|March 13, 2008
[Current situation and future perspectives of digital mammography]R Schulz-Wendtland, K-P Hermann, T Wacker, et al.Sozial- Und Praventivmedizin|October 1, 1981
[Excess mortality in out-patients psychiatry: first results of a Geneva study]L Raymond, B Cochet, C Garin, et al.The Journal of Nervous and Mental Disease|February 1, 1983
Validity of the Minnesota Multiphasic Personality Inventory (MMPI) to psychopathology in patients with epilepsyS Dikmen, B P Hermann, A J Wilensky, et al.Psychological Medicine|November 1, 1982
Psychopathology and seizure type in children with epilepsyS Whitman, B P Hermann, R B Black, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 26, 1998
IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expressionP Hermann, M Rubio, T Nakajima, et al.Acta Microbiologica Et Immunologica Hungarica|June 17, 2005
Incidence of oropharyngeal candidosis in stem cell transplant (SCT) patientsP Hermann, Zsuzsanna Berek, G Kriván, et al.Epilepsia|January 19, 2006
Quantitative MRI biomarkers of cognitive morbidity in temporal lobe epilepsyTayo O Oyegbile, Abhik Bhattacharya, Michael Seidenberg, et al.Acta Microbiologica Et Immunologica Hungarica|May 30, 2008
In vitro activity of fluconazole and amphotericin B against Candida inconspicua clinical isolates as determined by the time-kill methodZsuzsanna Szabó, Georgina Sóczó, Cecilia Miszti, et al.Pageof 68